Trials / Completed
CompletedNCT00637351
A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays
A Study to Collect Blood and Urine Samples in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
GSK Biologicals is working on the development of a vaccine to protect elderly people from bacterial pneumonia. Diagnostic of bacterial pneumonia is difficult, and for the future studies in that project, it would be useful to have some easy non invasive tests. New clinical read-outs are needed to detect and identify the causative pathogen. These assays will be based on specific antigen detection in the urine or specific pathogen DNA detection in the blood. Technical and clinical validation of these assays will be realised at later stage with samples coming from epidemiological and/or phase III studies. To allow the development of such tests in GSK Biologicals laboratories, urine and blood samples are needed from subjects aged 65 or above who have diagnosed pneumonia. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sample | One blood sample will be collected at the time of screening for subjects |
| PROCEDURE | Urine sample | One urine sample will be collected at the time of screening for subjects |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-03-18
- Last updated
- 2014-01-13
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00637351. Inclusion in this directory is not an endorsement.